Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;46(10):e14357.
doi: 10.1111/jfbc.14357. Epub 2022 Aug 9.

The therapeutic role of nutraceuticals targeting the Nrf2/HO-1 signaling pathway in liver cancer

Khalid Saad Alharbi  1 , Waleed Hassan Almalki  2 , Mohammed Albratty  3 , Abdulkarim M Meraya  4 , Asim Najmi  3 , Govind Vyas  5 , Sachin Kumar Singh  6   7 , Kamal Dua  7   8 , Gaurav Gupta  9   10   11
Affiliations
Review

The therapeutic role of nutraceuticals targeting the Nrf2/HO-1 signaling pathway in liver cancer

Khalid Saad Alharbi et al. J Food Biochem. 2022 Oct.

Abstract

Liver cancer (L.C.) is the most common cause of cancer death in the United States and the fifth most common globally. The overexpression of nuclear factor E2 related factor 2 (Nrf2) and heme oxygenase 1 (HO-1) caused by oxidative stress has been associated with tumor growth, aggressiveness, treatment resistance, and poor prognosis. Nutraceuticals that inhibit Nrf2/HO-1 signaling may become the most effective strategy to treat liver cancer. Phytochemicals found in fruits and vegetables, also known as nutraceuticals, tend to emerge as chemopreventive agents, with the added benefit of low toxicity and high nutritional values. This paper reviews the present scientific knowledge of the Nrf2/HO-1 signaling as a possible target molecule for chemotherapeutic agents, its basic control mechanisms, and Nrf2/HO-1 inducers produced from natural products that might be employed as cancer chemopreventive drugs. The growing interest in the contribution of the Nrf2/ARE/HO-1 signaling in the development of liver cancer and the Use of nutraceuticals to treat liver cancer by targeting Nrf2/ARE/HO-1. PRACTICAL APPLICATIONS: An increase in Nrf2 expression indicates that Nrf2 is the most important player in liver cancer. Cancer patients are more resistant to chemotherapy because of this erroneous Nrf2 signaling. Furthermore, an increasing body of evidence indicates that activation of the Nrf2/HO-1 pathway results in the production of phase II detoxifying and antioxidant enzymes, which serve a defense purpose in cells. As a consequence, treating liver cancer. This master regulator may be a possibility. Nutraceuticals that reduce Nrf2/HO-1 signaling may be the most effective strategy for preventing liver cancer. The methods of action of numerous natural substances are examined in this article.

Keywords: HO-1; Nrf2; liver cancer; nutraceuticals; oxidative stress.

PubMed Disclaimer

References

REFERENCES

    1. Abo El-Magd, N. F., El-Mesery, M., El-Karef, A., & El-Shishtawy, M. M. (2021). Amelioration effect of black seed oil against high-fat diet-induced obesity in rats through Nrf2/HO-1 pathway. Journal of Food Biochemistry, 45(4), e13693. https://doi.org/10.1111/jfbc.13693
    1. Ahmad, A., Gupta, G., Afzal, M., Kazmi, I., & Anwar, F. (2013). Antiulcer and antioxidant activities of a new steroid from Morus alba. Life Sciences, 92(3), 202-210.
    1. Alharbi, K. S., Afzal, O., Kazmi, I., Shaikh, M. A. J., Thangavelu, L., Gulati, M., Singh, S. K., Jha, N. K., Gupta, P. K., Chellappan, D. K., & Chellappan, D. K. (2022). Nuclear factor-kappa B (NF-κB) inhibition as a therapeutic target for plant nutraceuticals in mitigating inflammatory lung diseases. Chemico-Biological Interactions, 354, 109842.
    1. Alharbi, K. S., Almalki, W. H., Alzarea, S. I., Kazmi, I., Al-Abbasi, F. A., Afzal, O., Altamimi, A. S., Singh, S. K., Dua, K., & Gupta, G. (2022). A narrative review on the biology of piezo1 with platelet-rich plasma in cardiac cell regeneration. Chemico-Biological Interactions, 110011, 110011.
    1. Alharbi, K. S., Fuloria, N. K., Fuloria, S., Rahman, S. B., Al-Malki, W. H., Shaikh, M. A. J., Thangavelu, L., Singh, S. K., Allam, V. S., Jha, N. K., & Chellappan, D. K. (2021). Nuclear factor-kappa B and its role in inflammatory lung disease. Chemico-Biological Interactions, 345, 109568.

Publication types

MeSH terms

LinkOut - more resources